Drug recall notice for phenytoin oral suspension
March 4, 2020
The manufacturer of phenytoin is voluntarily recalling this medicine because it may not re-suspend when shaken, which could result in under or over-dosing
Drug news and alerts
Get the latest news on drug recalls, safety alerts, new therapies and other important updates.
Drug recall notice for lorcaserin
February 21, 2020
The Food and Drug Administration (FDA) has issued a voluntary recall of lorcaserin drugs due to an impurity used in the manufacturing of these medicines.
Drug recall notice for nizatidine
January 29, 2020
The Food and Drug Administration (FDA) has issued a voluntary recall of nizatidine drugs due to an impurity used in the manufacturing of these medicines.
Ongoing drug recall notice for ranitidine
January 16, 2020
The FDA continues to monitor and may add more manufacturers to the recall for ranitidine, a drug used to treat ulcers and other conditions where reduction of gastric secretion and acid output is desirable.
Drug recall notice for Natpara
September 26, 2019
The manufacturer of NATPARA, a drug used to treat hypocalcemia in patients with hypoparathyroidism, is issuing a recall of all doses on the market because of a potential issue.
Drug recall notice for irbesartan and irbesartan-containing drug products
January 21, 2019
The Food and Drug Administration (FDA) has issued a voluntary recall of select irbesartan-containing drugs due to an impurity used in the manufacturing of these medicines.
Drug recall notice for losartan and losartan-containing drug products
January 4, 2019
The Food and Drug Administration (FDA) has issued a voluntarily recall of select losartan containing drugs due to an impurity used in the manufacturing of these medicines.
Drug recall notice for valsartan and valsartan containing drug products
November 20, 2018
The Food and Drug Administration (FDA) has issued a voluntary recall of select generic valsartan and valsartan containing drugs due to an impurity used in the manufacturing of these medicines.
Drug recall notice for ondansetron orally disintegrating tablets and risperidone orally disintegrating tablets
August 6, 2018
Novartis and Sandoz Inc. have voluntarily recalled certain blister card packages distributed in the U.S.
Drug recall notice for Ventolin HFA Inhaler
June 1, 2017
The maker of Ventolin HFA Inhaler® has voluntarily recalled select lots from the U.S. marketplace. This recall was initiated due to a defect in certain lots of the inhaler that causes the product to deliver fewer doses than indicated.
Drug recall notice for EpiPen and EpiPen Jr Auto-Injector
June 1, 2017
The maker of EpiPen® and EpiPen Jr® Auto-Injectors has voluntarily recalled selected lots distributed in the U.S. and other markets. This recall was initiated due to reports of possible device malfunctions that could result in the devices failing to activate or requiring increased force to activate in an emergency or life-threatening situation.